Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV. A cross-sectional population-based study.
de Lazzari E, Nomah DK, Blanco JL, Rico N, Filella X, Egri N, Ruiz R, Marcos MA, Mosquera MDM, Alcamí J, Sánchez-Palomino S, Bruguera A, Hurtado C, Rovira C, Ambrosioni J, Chivite I, González-Cordón A, Inciarte A, Laguno M, Martínez-Rebollar M, Mora L, Torres B, Díaz Y, Martínez E, Mallolas J, Miro JM; Hospital Clinic HIV investigators. de Lazzari E, et al. Among authors: mora l. Int J Infect Dis. 2024 Oct 16:107266. doi: 10.1016/j.ijid.2024.107266. Online ahead of print. Int J Infect Dis. 2024. PMID: 39423949 Free article.
Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens.
Burgos J, Moreno-Fornés S, Reyes-Urueña J, Bruguera A, Martín-Iguacel R, Raventos B, Llibre JM, Imaz A, Peraire J, Orti AJ, Dalmau D, Casabona J, Miró JM, Falcó V; PISCIS study group. Burgos J, et al. J Antimicrob Chemother. 2022 Dec 23;78(1):108-116. doi: 10.1093/jac/dkac361. J Antimicrob Chemother. 2022. PMID: 36308326
Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study.
Martínez E, Foncillas A, Téllez A, Fernández S, Martínez-Nadal G, Rico V, Tomé A, Ugarte A, Rinaudo M, Berrocal L, De Lazzari E, Miró JM, Nicolás JM, Mallolas J, De la Mora L, Castro P. Martínez E, et al. Among authors: de la mora l. Infection. 2024 Oct 11. doi: 10.1007/s15010-024-02402-x. Online ahead of print. Infection. 2024. PMID: 39392586
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
Ugarte A, De La Mora L, De Lazzari E, Chivite I, Fernández E, Inciarte A, Laguno M, Ambrosioni J, Solbes E, Berrocal L, González-Cordón A, Martínez-Rebollar M, Foncillas A, Calvo J, Blanco JL, Martínez E, Mallolas J, Torres B. Ugarte A, et al. Among authors: de la mora l. J Antimicrob Chemother. 2024 Sep 3;79(9):2343-2353. doi: 10.1093/jac/dkae235. J Antimicrob Chemother. 2024. PMID: 39045754 Clinical Trial.
524 results